logo
Select company
Select metric
352.33%Interest Expense Margin
VS
Market
1
Sector
4
Industry
-
History
-
$ 0.38Close
$ 0.09 - $ 2.94 52-Week Range
Ticker Information

Ticker

IXHL

Company Name

INCANNEX HEALTHCARE INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

INCANNEX HEALTHCARE INC - Interest Expense Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IXHL - Int. Exp. % Historical data
DateInterest ExpenseInterest Expense MarginRevenues
6/30/2025$ 303K352.33%$ 86K
3/31/2025$ 303K309.18%$ 98K
12/31/2024$ 171K174.49%$ 98K
9/30/2024$ 00%$ 86K
6/30/2024$ 00%$ 12K
12/31/2023$ 00%$ 0
6/30/2023$ 00%$ 0
12/31/2022$ 00%$ 788.65K
6/30/2022$ 00%$ 788.65K
6/30/2021$ 00%$ 1.97M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INCANNEX HEALTHCARE INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
  • Over the past 5 years, INCANNEX HEALTHCARE INC's average Int. Exp. % has been 92.89%.
  • The median Int. Exp. % for INCANNEX HEALTHCARE INC during this period was 0%
  • INCANNEX HEALTHCARE INC reached its highest Int. Exp. % over the past 5 years at 352.33%.
  • The lowest Int. Exp. % recorded by INCANNEX HEALTHCARE INC in the same timeframe 0%

INCANNEX HEALTHCARE INC's Int. Exp. % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. % Benchmarks
CompanyInt. Exp. %
LYEL : LYELL IMMUNOPHARMA INC 0%CTOR : CITIUS ONCOLOGY INC -SERA : SERA PROGNOSTICS INC 15.74%STEX : STREAMEX CORP 84.62%INMB : INMUNE BIO INC 0%TIL : INSTIL BIO INC -NVCT : NUVECTIS PHARMA INC -TLPH : TALPHERA INC 0%CV : CAPSOVISION INC -CBIO : CRESCENT BIOPHARMA INC -

Definition of Interest Expense Margin

[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Int. Exp. / Revenues
(=) Int. Exp. %
Int. Exp. % for INCANNEX HEALTHCARE INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 604.88K ]
(=) Int. Exp. % [ 0% ]

IXHL - Interest Expense Margin, Last 5 years

0%

Minimum

Jun 30, 2020

352.33%

Maximum

Jun 30, 2025

92.89%

Average

0%

Median

Int. Exp. % Benchmark Analysis

The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
filtered constituents3.15K
min-4.94%
max8.49%
average1.63%
median0.79%
std2.2%